AI-generated summary
This retrospective review of 21 patients with Riehl's melanosis examined repeated mid-fluence Q-switched Nd:YAG 1064-nm laser treatment. The authors report that the mean melasma area and severity index score fell from 12.53 to 5.98, with 16 of 21 patients rated moderately or very much improved, and no severe side effects. The authors describe the treatment as possibly effective and safe, but the study was retrospective and uncontrolled.
- Participants
- 21
- Who or what was studied
- Adults with Riehl's melanosis (mean age 57.00 years; 20 female and 1 male)
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The study was a retrospective review of a small number of patients without a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 5 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Fluence, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.